Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
Abstract In December 2019, numerous coronavirus disease 2019 (COVID-19) cases were reported in Wuhan, China, which has since spread throughout the world. However, its impact on rheumatoid arthritis (RA) patients is unknown. Herein, we report a case of COVID-19 pneumonia in a 61-year-old female RA patient who was receiving conventional disease-modifying antirheumatic drugs (cDMARDs). The patient presented with a 4-day history of myalgia and febrile sensation. COVID-19 was confirmed by real-time polymerase chain reaction (PCR). Chest X-ray showed increased opacity on the right lower lung area, and C-reactive protein level was slightly elevated. The patient was treated with antiviral agents (lopinavir/ritonavir), and treatment with cDMARDs was discontinued except hydroxychloroquine. Her symptoms and laboratory results gradually improved. Three weeks later, real-time PCR for COVID-19 showed negative conversion, and the patient was discharged without any complications..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Rheumatology international - 40(2020), 6 vom: 20. Apr., Seite 991-995 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Song, Jehun [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
© Springer-Verlag GmbH Germany, part of Springer Nature 2020 |
---|
doi: |
10.1007/s00296-020-04584-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC204493261X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC204493261X | ||
003 | DE-627 | ||
005 | 20230511190557.0 | ||
007 | tu | ||
008 | 200820s2020 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00296-020-04584-7 |2 doi | |
035 | |a (DE-627)OLC204493261X | ||
035 | |a (DE-He213)s00296-020-04584-7-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Song, Jehun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Springer-Verlag GmbH Germany, part of Springer Nature 2020 | ||
520 | |a Abstract In December 2019, numerous coronavirus disease 2019 (COVID-19) cases were reported in Wuhan, China, which has since spread throughout the world. However, its impact on rheumatoid arthritis (RA) patients is unknown. Herein, we report a case of COVID-19 pneumonia in a 61-year-old female RA patient who was receiving conventional disease-modifying antirheumatic drugs (cDMARDs). The patient presented with a 4-day history of myalgia and febrile sensation. COVID-19 was confirmed by real-time polymerase chain reaction (PCR). Chest X-ray showed increased opacity on the right lower lung area, and C-reactive protein level was slightly elevated. The patient was treated with antiviral agents (lopinavir/ritonavir), and treatment with cDMARDs was discontinued except hydroxychloroquine. Her symptoms and laboratory results gradually improved. Three weeks later, real-time PCR for COVID-19 showed negative conversion, and the patient was discharged without any complications. | ||
650 | 4 | |a Coronavirus | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Pneumonia | |
650 | 4 | |a Rheumatoid arthritis | |
650 | 4 | |a Disease-modifying antirheumatic drugs | |
700 | 1 | |a Kang, Seongmin |4 aut | |
700 | 1 | |a Choi, Seung Won |0 (orcid)0000-0001-5767-221X |4 aut | |
700 | 1 | |a Seo, Kwang Won |0 (orcid)0000-0003-0504-6924 |4 aut | |
700 | 1 | |a Lee, Sunggun |0 (orcid)0000-0003-3640-9185 |4 aut | |
700 | 1 | |a So, Min Wook |0 (orcid)0000-0001-5027-0410 |4 aut | |
700 | 1 | |a Lim, Doo-Ho |0 (orcid)0000-0002-8012-7364 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d Springer Berlin Heidelberg, 1981 |g 40(2020), 6 vom: 20. Apr., Seite 991-995 |w (DE-627)129098183 |w (DE-600)8286-7 |w (DE-576)014434903 |x 0172-8172 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2020 |g number:6 |g day:20 |g month:04 |g pages:991-995 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00296-020-04584-7 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
951 | |a AR | ||
952 | |d 40 |j 2020 |e 6 |b 20 |c 04 |h 991-995 |